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There	is	uncertainty	about	whether	hypoxic	injury	accompanying	donor	death	from	
ligature	asphyxiation	influences	renal	transplant	outcomes,	particularly	for	recipients	
of	kidneys	donated	after	circulatory	death	(DCD).	The	UK	Registry	analysis	was	un‐
dertaken	to	determine	transplant	outcomes	in	recipients	of	kidneys	from	donors	who	
died	following	ligature	asphyxiation.	From	2003	to	2016,	2.7%	(n	=	521)	of	potential	
organ	 donors	 died	 following	 ligature	 asphyxiation	 (mostly	 suicide	 by	 hanging).	Of	
these,	409	(78.5%)	donated	kidneys	for	transplantation	(46.9%	donation	after	brain	
death	[DBD]	and	53.1%	DCD	donors)	resulting	in	650	kidney	transplants.	Compared	
to	 other	 deceased	 donors,	 those	 dying	 from	 ligature	 asphyxiation	 were	 younger,	
more	often	male,	and	had	less	hypertension.	Unadjusted	patient	and	graft	survival	
were	superior	for	recipients	of	both	DBD	and	DCD	kidneys	from	donors	dying	after	
ligature	asphyxiation,	although	after	adjustment	for	donor/recipient	variables,	trans‐
plant	outcomes	were	similar.	A	case–control	matched	analysis	confirmed	transplant	
outcomes	for	those	who	received	kidneys	from	donors	dying	after	ligature	asphyxia‐
tion	were	similar	to	controls.	Although	caution	is	required	in	interpreting	these	find‐
ings	 because	 of	 potential	 selection	 bias,	 kidneys	 from	 donors	 dying	 of	 ligature	
asphyxiation	suffer	an	additional	warm	ischemic	insult	that	does	not	apparently	ad‐
versely	influence	transplant	outcomes,	even	for	kidneys	from	DCD	donors.
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1  | INTRODUC TION
Kidneys	 from	 deceased	 donors	 who	 have	 undergone	 ligature	 as‐
phyxiation	are	often	used	for	transplantation,	although	there	is	little	
information	 on	whether	 this	 mode	 of	 death	 influences	 transplant	
outcomes.	Ligature	asphyxiation	 is	usually	 the	 result	of	attempted	
suicide	by	hanging	and	is	one	of	the	most	common	methods	of	sui‐
cide.	Moreover,	 suicide	 remains	 a	 common	 cause	 of	 death	world‐
wide,	 especially	 in	 the	 younger	 population.1‒3	 In	 situations	where	
attempted	resuscitation	and	hospitalization	have	occurred	following	
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ligature	asphyxiation,	individuals	may	become	potential	brain	death	
(DBD)	or	circulatory	death	 (DCD)	organ	donors.	However,	 ligature	
asphyxiation	 in	 these	circumstances	 is	associated	with	a	period	of	
global	 tissue	 hypoxia,	 often	 of	 an	 unknown	 duration,	 which	 may	
cause	warm	ischemic	injury	of	the	transplantable	organs.4‒6	During	
ligature	 asphyxiation	 there	 is	 compression	 of	 the	 carotid	 arteries,	
the	 jugular	 veins,	 and	 the	 trachea,	 resulting	 in	 raised	 intracranial	
pressure,	cerebral	edema,	and	catastrophic	brain	injury.7 In addition 
to	the	above,	the	victims	of	ligature	asphyxiation	may	also	develop	
pulmonary	edema	and	multiorgan	failure	secondary	to	global	tissue	
hypoxia.7	While	hypoxic	tissue	injury	following	ligature	asphyxiation	
is	a	concern	in	DBD	donors,	it	may	have	an	even	greater	impact	on	
organs	from	DCD	donors	where	the	organs	are	also	subjected	to	a	
second	period	of	warm	ischemic	injury	between	cardiac	arrest	and	
cold	perfusion	of	the	organs.8	However,	many	potential	donors	who	
die	 following	 ligature	 asphyxiation	 are	 relatively	 young	 and	 previ‐
ously	healthy,	and	therefore	might	be	a	source	of	good	quality	kid‐
neys that can be used safely for transplantation.3
However,	 the	 evidence	 on	 which	 to	 base	 decisions	 regarding	
the	use	of	organs	from	deceased	donors	following	ligature	asphyx‐
iation	 is	 limited	 and	 comprises	 case	 reports	 and	 single‐center	 ex‐
periences.4‒6	 Moreover,	 the	 published	 experience	 relates	 almost	
exclusively	to	DBD	donors,	with	little	or	no	published	evidence	for	
DCD	donors	who	are	becoming	an	increasingly	important	source	of	
organs	for	transplantation.4‒6
To	 improve	 the	 evidence	base	 and	 aid	 decision	making	on	 the	
use	of	organs	from	donors	who	die	following	ligature	asphyxiation,	
we	undertook	 a	 retrospective	national	 (the	United	Kingdom	 [UK])	
cohort	study	of	all	kidney	transplants	performed	using	organs	from	
DBD	and	DCD	donors.
2  | METHODS
2.1 | Identification of deceased donors who died 
secondary to ligature asphyxiation
The	UK	Transplant	Registry	(UKTR)	was	examined	to	identify	deceased	
organ	donors	 in	 the	UK	between	January	1,	2003	and	December	31,	
2016	who	died	secondary	to	ligature	asphyxiation.	Death	from	ligature	
asphyxiation	(including	suicide	by	hanging	and	strangulation)	is	not	cur‐
rently	one	of	the	65	designated	causes	of	death	in	the	UKTR	and	so	to	
identify	organ	donors	who	may	have	died	from	ligature	asphyxiation,	the	
free	text	entries	for	all	deceased	organ	donors	were	searched	using	the	
search	 terms	 “strangled”,	 “strangulation”,	 “hanging”,	 “ligature”,	 “suicide”,	
“hung”,	“noose”,	“asphyxiation”,	and	any	abbreviations	or	common	mis‐
spellings	of	these	terms.	The	free	text	entries	of	the	donors	 identified	
were	then	manually	reviewed.	The	free	text	entries	of	all	organ	donors	
whose	cause	of	death	was	stated	as	“other	trauma‐suicide”	and	“other	
trauma‐unknown	 causes”	 were	 also	 manually	 reviewed	 to	 identify	 a	
further	cohort	of	donors	who	died	secondary	to	 ligature	asphyxiation.	
Information	on	whether	a	donor	had	a	previous	history	of	intravenous	
drug	use	(IVDU)	or	imprisonment	was	collected	as	described	previously.9
For	the	purposes	of	this	study,	“potential	donors”	were	defined	
as	deceased	donors	for	whom	consent/authorization	for	organ	do‐
nation	had	been	obtained,	“proceeding	organ	donors”	as	deceased	
donors	who	had	one	or	more	solid	organs	 removed	 for	 transplan‐
tation	on	 the	basis	 that	 recipient	 centers	had	provisionally	 agreed	
to	use	them	for	transplantation,	and	“utilised	organ	donors”	as	pro‐
ceeding	organ	donors	whose	organs	where	eventually	transplanted.	
Only	Maastricht	 category,	 three	DCD	donors	 and	 all	DBD	donors	
were	included	in	the	analysis.8
2.2 | Identification of recipients who 
received organs from donors who died from ligature 
asphyxiation
The	UKTR	was	examined	to	identify	the	recipients	of	kidneys	(both	
single	and	dual	kidney	transplant	recipients)	from	donors	who	died	
secondary	 to	 ligature	 asphyxiation	 in	 the	UK	 between	 January	 1,	
2003	and	December	31,	2016	and	 information	on	death	censored	
graft	 survival	 and	 patient	 survival	 was	 collected.	 In	 recipients	 of	
renal	allografts,	one	year	eGFR	was	calculated.10
All	cause	graft	failure	was	taken	as	time	from	transplantation	to	
graft	nephrectomy	or	return	to	permanent	dialysis,	whichever	was	
earlier,	or	to	death	of	the	patient	with	a	functioning	graft.	Survival	
of	the	patient	was	defined	as	time	from	transplantation	until	death.	
We	defined	PNF	as	failure	of	a	graft	to	ever	function.	DGF	was	de‐
fined	as	the	need	for	dialysis	within	the	first	7	days	after	transplan‐
tation	(excluding	recipients	with	PNF).	Graft	survival	was	censored	
at	5	years.	Warm	ischemic	time	was	defined	as	the	time	from	circula‐
tory	arrest	to	cold	perfusion	of	the	kidneys.	Downtime	was	defined	
as either time from discovery of cardiac arrest until return of circu‐
lation	 following	 resuscitation	 or	when	 the	 free	 text	 entries	 in	 the	
registry	referred	to	the	time	as	downtime.
2.3 | Statistical analysis
Univariate	analysis	was	carried	out	using	the	Student’s	 t‐test	 for	
parametric	 continuous	 data	 and	 the	 Mann–Whitney	 U	 test	 for	
nonparametric	 continuous	 data.	 Comparisons	 between	 groups	
were	made	 using	 the	 χ2	 test	 for	 categorical	 data.	 Kaplan–Meier	
tables	were	 used	 to	 compare	 death‐censored	 graft	 survival	 and	
patient	survival.	The	univariate	logrank	test	was	used	to	test	dif‐
ferences in survival.
Cox	proportional	hazards	regression	model	was	fitted	with	fac‐
tors	known	to	have	impact	on	patient	and	graft	survival.	Patient	
and	graft	 survival	were	censored	at	1	year	 to	determine	 factors	
associated	with	 1‐year	 survival	 and	 at	 5	years	 to	 determine	 the	
factors	associated	with	5‐year	survival.	This	was	performed	as	a	
large	 proportion	 of	 donors	who	 died	 following	 ligature	 asphyx‐
iation	 had	 kidneys	 used	 for	 transplantation	 in	 the	 last	 3	years.	
Patients	without	 graft	 or	 patient	 follow‐up	 (n	=	79	 [0.4%])	were	
not	 included	 in	 the	 analysis.	 Log	 cumulative	 hazard	 plots	 were	
drawn	and	proportionality	of	hazards	were	checked	using	log–log	
plots.
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Multivariable	 linear	 regression	modeling	was	carried	out	 to	as‐
sess	the	impact	that	donor	cause	of	death	from	ligature	asphyxiation	
had	on	1	year	eGFR	and	creatinine.	Logistic	regression	analysis	was	
performed	to	assess	the	impact	of	donor	cause	of	death	by	ligature	
asphyxiation	on	potential	donors	proceeding	to	kidney	donation	and	
the	impact	of	this	cause	of	death	on	DGF	and	PNF	rates.
Multiple	imputations	were	used	to	account	for	missing	donor	
and	 recipient	 variables.	 There	 were	 no	 missing	 data	 for	 donor	
type,	 ethnicity,	 and	whether	 cause	 of	 death	was	 by	 ligature	 as‐
phyxiation.	 Missing	 information	 about	 past	 medical	 history	 of	
hypertension	and/or	diabetes	was	7.1%.	For	past	medical	history	
of	cardiac	disease	and	smoking	there	were	0.98%	and	2.3%	miss‐
ing	data,	respectively.	In	terms	of	recipient	characteristics,	there	
were	<1%	missing	data	for	recipient	gender,	HLA	mismatch	level,	
ethnicity,	and	recipient	sex,	<2%	for	CIT	and	37%	for	warm	isch‐
emic	time	in	DCD	donors.	Missing	data	were	assumed	to	be	miss‐
ing	at	random	and	the	missing	variables	had	an	arbitrary	missing	
pattern.	 The	 imputed	 variables	 were	 all	 independent	 variables.	
Missing	data	were	estimated	by	a	discriminant	function	approach	
for	categorical	variables,	a	 logistic	 regression	approach	for	ordi‐
nal	variables	and	linear	models	for	cumulative	variables.	The	FCS	
method	was	used	to	impute	missing	values	of	both	continuous	and	
class	variables	in	the	dataset	with	an	arbitrary	missing	pattern.	For	
each	analysis	requiring	multiple	imputations,	20	imputed	datasets	
were	created.
Donor‐related	variables	considered	for	inclusion	in	the	multivari‐
able	models	were	donor	age,	donor	type,	ethnic	group,	sex,	cause	of	
death,	past	medical	history	of	diabetes,	hypertension,	 and	cardiac	
disease,	previous	drug	abuse	and	smoking	history,	and	blood	group.	
Recipient	factors	included	were	recipient	age,	ethnicity,	sex,	sensiti‐
zation,	primary	renal	disease	(five	categories),	blood	group	(O,	A,	B,	
AB),	HLA	mismatch,	and	CIT.	Other	factors	considered	for	inclusion	
were	renal	transplant	unit,	which	was	included	as	a	random	effect,	
and	year	of	transplant	(as	an	ordinal	variable).
An	addition	to	the	above	multivariable	analyses,	a	case‐control	
propensity	score	matched	analysis	was	also	performed	to	examine	
transplant	outcomes	in	recipients	of	kidneys	from	donors	who	died	
following	 ligature	 asphyxiation.	 Propensity	 scores	were	 calculated	
using	logistic	regression	on	the	probability	of	a	recipient	receiving	a	
kidney	from	a	donor	who	died	following	ligature	asphyxiation.	The	
scores	were	then	used	to	match	recipients	of	kidneys	from	donors	
who	 died	 following	 ligature	 asphyxiation	 to	 recipients	 of	 kidneys	
from	all	other	deceased	donors	with	similar	propensity	scores.	This	
was	accomplished	with	1:1	matching.	The	following	covariates	were	
included in the estimation of propensity scores since they have been 
shown	 in	previous	analyses	of	 the	UK	dataset	 to	 impact	on	 trans‐
plant	outcomes:	donor	age,	recipient	age,	donor	past	medical	history	
of	hypertension,	primary	 renal	disease,	HLA	mismatch	grade,	 cold	
ischemic	time	(CIT),	donor	weight,	donor	type	(DBD	and	DCD),	and	
transplant year.11,12
All	 analyses	 were	 performed	 using	 Statistical	 Analysis	 System	
(SAS)	 (version	 9.3;	 SAS	 Institute	 Inc.,	 Cary,	 NC)	 and	 P	<	.05	 were	
deemed	to	be	statistically	significant.13
3  | RESULTS
3.1 | Potential and proceeding kidney donors who 
died secondary to ligature asphyxiation
Over	the	14‐year	study	period	(January	1,	2003	to	December	31,	
2016),	 2.7%	 (n	=	521)	 of	 all	 the	 potential	 UK	 organ	 donors	 died	
secondary	to	ligature	asphyxiation.	Nearly	all	(98.7%)	were	a	result	
of	attempted	suicide,	but	a	small	proportion	 (1.3%)	was	acciden‐
tal.	From	this	pool	of	potential	donors,	409	(78.5%)	subsequently	
proceeded	 to	 donate	 one	 or	 more	 kidneys	 for	 transplantation.	
By	comparison,	only	69.9%	of	potential	donors	who	died	from	all	
causes	other	than	ligature	asphyxiation	proceeded	to	donate	kid‐
neys for transplantation (P	<	.001).	Of	 the	potential	 donors	who	
died	from	ligature	asphyxiation	and	proceeded	to	kidney	donation,	
192	 (46.9%)	were	DBD	donors	 and	217	 (53.1%)	were	 controlled	
DCD donors.8
The	proportion	of	potential	DBD	donors	who	died	after	ligature	
asphyxiation	and	proceeded	 to	donate	kidneys	was	 similar	 to	 that	
for	 all	 other	 types	 of	 potential	DBD	donors	 (91.4%	 vs.	 87.6%,	 re‐
spectively,	P	=	.092).	 Compared	 to	 potential	DBD	donors,	 a	 lower	
proportion	of	all	potential	DCD	donors	proceeded	to	kidney	dona‐
tion,	 irrespective	of	whether	the	cause	of	death	was	from	ligature	
asphyxiation	 (50.1%	vs.	87.7%,	P	<	.001).	However,	more	potential	
DCD	donors	proceeded	to	donate	organs	after	ligature	asphyxiation	
than	after	causes	of	death	other	than	 ligature	asphyxiation	 (69.8%	
vs.	49.4%,	P	<	.001).
Relatively	 little	 information	 was	 available	 in	 the	 transplant	
registry	regarding	the	physiological	events	occurring	around	the	
time	of	 ligature	asphyxiation.	A	 total	of	203	 (39%)	potential	do‐
nors	who	 died	 following	 ligature	 asphyxiation	were	 reported	 to	
have	had	a	cardiac	arrest	at	the	time	of	ligature	asphyxiation	and	
had	a	recorded	“downtime”	 (ie,	 the	 length	of	 time	following	car‐
diac	arrest	until	return	of	circulation	at	the	time	of	resuscitation).	
Of	these,	73.8%	proceeded	to	donate	kidneys	for	transplantation	
compared	 to	 80.7%	 of	 potential	 donors	 with	 no	 stated	 down‐
time (P	=	.125).	The	median	 recorded	downtime	was	25	minutes	
(interquartile	 range	 [IQR]	 15‐40	minutes).	 Of	 donors	 who	 died	
from	ligature	asphyxiation,	DCD	donors	had	significantly	shorter	
recorded	downtimes	compared	 to	DBD	donors	 (median	22	min‐
utes	 [IQR	15‐34.5	minutes]	vs.	median	33	minutes	 [IQR	19‐45.5	
minutes)],	P	=	.0151).
3.2 | Factors associated with potential deceased 
donors proceeding to donate kidneys for 
transplantation
A	 multivariable	 analysis	 was	 undertaken	 on	 all	 potential	 donors	
(n	=	19	310)	 to	 determine	 whether	 death	 from	 ligature	 asphyxia‐
tion	was	independently	associated	with	a	potential	donor	proceed‐
ing	to	donate	one	or	more	kidneys	for	transplantation.	As	shown	in	
Table	1,	the	following	donor	factors	were	associated	with	proceed‐
ing	to	donate	kidneys:	donor	age;	DBD	donor	type;	no	past	medical	
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history	 of	 diabetes,	 hypertension	 or	 cardiac	 disease;	 and	 white	
ethnicity.	Following	adjustment	for	the	above	donor	variables,	liga‐
ture	asphyxiation	in	potential	donors	remained	strongly	associated	
with	an	increased	likelihood	of	kidney	donation	for	transplantation	
(odds	ratio	1.211	[95%	confidence	interval	1.080‐1.357],	P	<	.001).	
A	further	multivariable	analysis	was	performed	to	assess	what	fac‐
tors	influenced	donors	who	died	following	ligature	asphyxiation	to	
proceed	 to	 kidney	 donation.	 Table	 2	 demonstrates	 that	 younger	
donor	 age;	 DBD	 donor	 type;	 no	 history	 of	 smoking	 or	 liver	 dis‐
ease;	no	history	of	intravenous	drug	use;	and	not	having	been	im‐
prisoned	were	all	independently	associated	with	a	donor	who	died	
following	 ligature	asphyxiation	proceeding	 to	donate	a	kidney	 for	
transplantation.
3.3 | Clinical characteristics of proceeding kidney 
donors (DBD and DCD) who died from ligature 
asphyxiation
The	clinical	characteristics	of	proceeding	kidney	donors	who	died	
after	ligature	asphyxiation	and	those	who	died	from	all	other	causes	
are	shown	in	Table	3;	the	data	are	shown	separately	for	DBD	and	
DCD.	Both	DBD	and	DCD	kidney	donors	who	died	 from	 ligature	
asphyxiation	were	 significantly	 younger	 and	 a	 greater	 proportion	
were	male	than	those	DBD	and	DCD	donors	who	died	from	other	
causes.
Donors	 who	 died	 following	 ligature	 asphyxiation	 (both	 DBD	
and	DCD	donors)	had	a	markedly	lower	incidence	of	hypertension	
and	cardiac	disease	than	donors	who	died	from	causes	other	than	
ligature	 asphyxiation.	 The	 proportion	 of	 kidney	 donors	who	 died	
following	 ligature	asphyxiation	who	had	diabetes	mellitus	was	nu‐
merically	lower	than	that	of	donors	who	died	from	all	other	causes,	
but	the	difference	was	only	significant	in	the	case	of	DCD	donors.	
More	kidney	donors	 (both	DBD	and	DCD)	who	died	following	 lig‐
ature	asphyxiation	had	a	history	of	smoking	compared	to	all	other	
TA B L E  1  Factors	associated	with	potential	deceased	donors	
proceeding	to	donate	1	or	more	kidneys	for	transplantation.	19	310	
potential	deceased	donors	were	analyzed	by	logistic	regression
Donor characteristics 
(n = 19 310)
Odds ratio (95% confi‐
dence interval) P value
Donor	age 0.983	(0.981‐0.986) <.001
Donor ethnicity
White 1.00 —
Non‐white 0.794	(0.731‐0.863) <.001
Donor type
DCD 1.00 —
DBD 2.536	(2.444‐2.631) <.001
Past medical history of diabetes
No 1.00 —
Yes 0.753	(0.707‐0.803) <.001
Past medical history of hypertension
No 1.00 —
Yes 0.902	(0.863‐0.942) <.001
Past medical history of cardiac disease
No 1.00 —
Yes 0.863	(0.819‐0.908) <.001
Past	medical	history	of	smoking
No 1.00 —
Yes 0.970	(0.933‐1.01) .115
Donor cause of death
No	ligature	
asphyxiation
1.00 —
Ligature	asphyxiation 1.211	(1.080‐1.357) .001
DBD,	donation	after	brain	death;	DCD,	donation	after	circulatory	death.
TA B L E  2  Factors	associated	with	potential	donors	who	died	
following	ligature	asphyxiation	proceeding	to	donate	1	or	more	
kidneys	for	transplantation
Donor characteristics 
(n = 521)
Odds ratio (95% confi‐
dence interval) P value
Donor	age	(y) 0.975	(0.965‐0.985) <.001
Donor ethnicity
White 1.00 —
Non‐white 1.259	(0.829‐1.911) .279
Donor type
DCD 1.00 —
DBD 1.973	(1.664‐2.340) <.001
Past medical history of diabetes
No 1.00 —
Yes 0.951	(0.630‐1.436) .811
Past medical history of hypertension
No 1.00 —
Yes 1.223	(0.850‐1.758) .278
Past medical history of cardiac disease
No 1.00 —
Yes 0.901	(0.514‐1.580) .716
Past	medical	history	of	smoking
No 1.00 —
Yes 0.829	(0.706‐0.973) .022
History	of	intravenous	drug	use
No 1.00 —
Yes 0.543	(0.412‐0.715) <.001
History of imprisonment
No 1.00
Yes 1.438	(1.055‐1.961) .022
History of liver disease
No 1.00
Yes 0.479	(0.324‐0.709) <.001
Downtime	(min) 1.005	(0.994‐1.016) .387
Predonation creatinine 
(umol/L)
1.000	(0.999‐1.002) .911
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TA B L E  3  Clinical	characteristics	of	proceeding	kidney	donors	who	died	from	ligature	asphyxiation	compared	to	all	other	deceased	donors
DBD donors who died following 
ligature asphyxiation (n = 192)
DBD donors who died from all 
other causes (n = 8846) P value
DCD donors who died following 
ligature asphyxiation (n = 217)
DCD donors who died from all 
other causes (n = 4291) P value
Age	(y) 32	(22‐43) 49	(37‐59) <.001 34	(24‐47) 54	(43‐65) <.001
Male/female 113	(58.9%)/79	(41.1%) 4448	(50.3%)/4394	(49.7%) .074 160	(73.7%)/57	(26.3%) 2583	(60.2%)/1708	(39.8%) <.001
Unknown/unstated 0 4	(<0.5%) 0 0
White ethnicity 181	(94.3%) 8404	(95.0%) .658 208	(95.9%) 4145	(96.6%) .557
History of hypertension
Yes/no 5	(2.6%)/187	(97.4%) 2172	(24.6%)/6480	(73.3%) <.001 14	(6.5%)/197	(90.8%) 1222	(28.5%)/2780	(64.8%) <.001
Unknown/unstated 0‐ 194	(2.2%) 6	(2.8%) 289	(6.7%)
History of cardiac disease
Yes/No 1	(0.5%)/189	(98.4%) 746	(8.4%)/7900(89.3%) <.001 5	(2.3%)/199	(91.7%) 598	(13.9%)/3359	(78.3%) <.001
Unknown/unstated 2	(1.0%) 200	(2.3%) 13	(5.9%) 334	(7.8%)
History of diabetes
Yes 8	(4.2%)/183	(95.3%) 480	(5.4%)/8272(93.5%) .565 5	(2.3%)/201	(92.6%) 325	(7.6%)/3696	(86.1%) .007
Unknown/unstated 1	(0.5%) 94	(1.1%) 11	(4.9%) 270	(6.3%)
Smoking	history
Yes/no 125	(65.1%)/65(33.9%) 4231	(47.8%)/4522	(51.1%) <.001 140	(64.5%)/74	(34.1%) 1802	(42.0%)/2233	(52.1%) <.001
Unknown/unstated 2	(1.0%) 93	(1.1%) 3	(1.4%) 256	(6.0%)
Predonation serum 
creatinine	(umol/L)
121	(93‐162) 84	(67‐107) <.001 101	(80‐129) 84	(65‐108) <.001
Missing 0 9	(<0.5%) 3	(1.4%) 223	(5.2%)
DBD,	donation	after	brain	stem	death;	DCD,	donation	after	circulatory	death;	IQR,	interquartile	range.
Data	shown	as	median	and	IQR.
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TA B L E  4  Clinical	characteristics	of	renal	transplant	recipients	from	organ	donors	who	died	from	ligature	asphyxiation	compared	to	those	who	died	of	all	other	causes
DBD donors following ligature 
asphyxiation (n = 294)
All other DBD donors 
(n = 14 382) P value
DCD donors following ligature 
asphyxiation (n = 356)
All other DCD donors 
(n = 6662) P value
Age	(y) 43	(29‐53) 48	(37‐58) <.001 47	(38‐57) 55	(46‐63) <.001
Male/female	(%) 182	(61.9%)/112(38.1%) 8774	(61.0%)/5599	
(39.0%)
.879 211	(59.3%)/143(40.2%) 4406	(66.2%)/2250	
(33.8%)
.001
White	ethnicity	(%) 203	(69.1%) 11006	(76.5%) .003 284	(79.8%) 5167	(77.6%) .396
Dual	kidney	transplant	(%) 0	(0) 101(0.7%) .352 3	(0.8%) 318	(4.7%) .01
cRF	>	85% 44	(15.0%) 1805	(12.6%) .217 20	(5.6%) 293	(4.4%) .304
HLA	mismatch	grade .638 .168
1 58	(19.7%) 2728	(19.0%) 9	(2.5%) 226	(3.4%)
2 124	(42.2%) 5841	(40.6%) 96	(26.7%) 1581	(23.7%)
3 106	(36.1%) 5327	(37.1%) 216	(59.8%) 3889	(58.4%)
4 6	(2.0%) 481	(3.3%) 40	(11.0%) 965	(14.5%)
Cold ischaemic time <.001 .248
<12	h 78	(27.1%) 2662	(18.5%) 110	(31.3%) 1977	(30.0%)
12‐18	h 129	(44.8%) 6820	(47.5%) 162	(46.4%) 2973	(45.1%)
18‐24	h 65	(22.6%) 3354	(23.3%) 68	(19.5%) 1320	(20.0%)
>24 h 16	(5.6%) 1395	(9.7%) 9	(2.6%) 322	(4.9%)
Warm	ischaemic	time	(min) ‐ ‐ 7	(6‐10) 8	(6‐10) .796
Primary renal disease .04 .192
Diabetic nephropathy 19	(6.4%) 1004	(7.0%) 26	(7.5%) 637	(9.5%)
Glomerulonephritis 38	(12.8%) 2497	(17.4%) 73	(20.8%) 1256	(18.8%)
Pyelonephritis 19	(6.4%) 1218	(8.5%) 24	(6.7%) 462	(7.0%)
Polycystic	kidney	disease 25	(8.5%) 1515	(10.5%) 42	(11.6%) 1011	(15.2%)
Other 193	(65.7%) 8147	(56.6%) 191	(53.5%) 3295	(49.5%)
cRF,	calculated	reaction	frequency;	DBD,	donation	after	brain	death;	DCD,	donation	after	circulatory	death;	HLA,	Human	Leucocyte	Antigen.	
HLA	mismatch	level	(levels	1‐4)	was	defined	according	to	the	UK	allocation	policy	for	kidneys	from	brain‐death	donors	and	was	based	on	the	mismatch	between	donor	and	recipient.14 aMissing	data	were	
<1%	gender	and	HLA	Mismacth	level	ethnicity	and	recipient	sex	and	<2%	for	cold	ischaemic	time,	37%	for	warm	ischaemic	time.
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deceased	donors.	DBD	and	DCD	donors	who	died	following	ligature	
asphyxiation	had	significantly	higher	predonation	serum	creatinine	
levels.
3.4 | Clinical characteristics of recipients of kidneys 
from donors who died following ligature asphyxiation
Donors	who	died	following	 ligature	asphyxiation	provided	kidneys	
for	 650	 kidney	 only	 transplants.	 The	 clinical	 characteristics	 of	 re‐
cipients	of	kidneys	from	DBD	and	DCD	donors	who	died	following	
ligature	asphyxiation	and	those	who	died	from	all	other	causes	are	
shown	in	Table	4.	Recipients	of	kidneys	from	donors	who	died	fol‐
lowing	 ligature	asphyxiation	were	significantly	younger	than	those	
receiving	kidneys	from	donors	who	died	from	other	causes,	but	were	
of	similar	gender	and	ethnicity.	There	was	no	difference	in	the	calcu‐
lated	reaction	frequency	(analogous	to	calculated	panel	reactivity)	or	
human	leukocyte	antigen	(HLA)	mismatch	between	recipients	of	kid‐
neys	from	deceased	donors	who	died	following	ligature	asphyxiation	
and	those	who	died	from	all	other	causes.	The	primary	renal	disease	
in	recipients	of	kidneys	from	DBD	and	DCD	donors	who	died	follow‐
ing	 ligature	 asphyxiation	was	broadly	 similar	 to	 that	 for	 recipients	
of	kidneys	 from	other	DBD	and	DCD	donors.	The	CITs	of	kidneys	
from	DBD	donors	who	died	following	ligature	asphyxiation	were	sig‐
nificantly	shorter	than	those	for	kidneys	from	all	other	DBD	donors.	
CITs	were	similar	for	kidneys	from	DCD	donors	who	died	following	
ligature	asphyxiation	and	all	 other	DCD	donors.	Over	 the	14‐year	
study	period	there	was	a	marked	increase	in	the	number	of	deceased	
donor	kidney	transplants	performed	 in	 the	UK,	predominantly	be‐
cause	of	an	increase	in	transplants	using	kidneys	from	DCD	donors	
(Figure	1A).	The	number	of	kidney	transplants	performed	from	both	
DBD	and	DCD	donors	who	died	following	ligature	asphyxiation	in‐
creased	progressively	over	 the	study	period	 (Figure	1B),	 such	 that	
F I G U R E  1  Number	of	renal	transplants	carried	out	from	
2003‐2015	from	(A)	all	deceased	donors	by	donor	type	(DBD	and	
DCD)	and	(B)	donors	who	died	following	ligature	asphyxiation	and	
donor	type	(DBD	and	DCD).	DBD,	donation	after	brain	death;	DCD,	
donation after circulatory death
A
B
F I G U R E  2  Kaplan‐Meier	estimates	of	(A)	patient	survival	from	renal	transplantation	from	DBD	donors	who	died	following	ligature	
asphyxiation	and	all	other	DBD	donors,	and	(B)	death	censored	graft	survival	from	renal	transplantation	from	DBD	donors	who	died	
following	ligature	asphyxiation	and	all	other	DBD	donors
A B
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half	 of	 the	 transplants	 using	 kidneys	 from	 such	 donors	were	 per‐
formed	in	the	last	4	of	the	14‐year	study	period.
3.5 | Outcomes in recipients of kidneys from donors 
who died following ligature asphyxiation
The	 results	 of	 survival	 analyses	 of	 patient	 and	 graft	 survival	 are	
shown	in	Figures	1‒4.	For	these	and	the	multivariable	analyses	the	
median	 follow‐up	 of	 kidney	 transplant	 recipients	 was	 48	months	
(IQR	24‐96	months).	For	kidney	transplant	recipients	transplanted	in	
2016,	the	median	follow‐up	was	96	days	(IQR	88‐356	days).
For	transplant	outcomes	when	comparing	recipients	of	kidneys	
from	 donors	 who	 died	 following	 ligature	 asphyxiation	 with	 those	
who	did	not,	we	chose	to	analyze	recipients	of	kidneys	from	DBD	
and	DCD	donors	separately.	For	recipients	of	kidneys	from	DBD	do‐
nors,	patient	survival	was	superior	for	those	who	received	kidneys	
from	donors	who	died	following	ligature	asphyxiation,	but	there	was	
no	difference	 in	graft	survival	 (Figure	2).	For	 recipients	of	kidneys	
from	DCD	donors,	both	patient	and	graft	 survival	were	better	 for	
those	who	 received	kidneys	 from	donors	who	died	 following	 liga‐
ture	asphyxiation	(Figure	3).	A	comparison	of	recipients	of	kidneys	
from	DBD	and	DCD	donors	who	died	following	ligature	asphyxiation	
showed	similar	patient	and	graft	survival	 (Figure	4).	Finally,	a	com‐
parison	 of	 recipients	 of	 kidneys	 from	 all	 kidney	 donors	 (DBD	 and	
DCD)	who	died	 following	 ligature	asphyxiation	and	 those	who	 re‐
ceived	kidneys	from	all	other	deceased	kidney	donors	demonstrated	
better	 patient	 and	 graft	 survival	 for	 those	 who	 received	 kidneys	
from	donors	who	died	following	ligature	asphyxiation	(Figure	5).
As	 already	 shown,	 significant	 differences	 were	 identified	 in	
donor	 and	 recipient	 demographics	 between	 recipients	 of	 kidneys	
from	donors	who	died	following	ligature	asphyxiation	and	all	other	
deceased	kidney	donors.	The	factors	considered	in	the	analyses	in‐
cluded	donor	and	recipient	age,	CIT,	donor	type	(DBD	or	DCD),	HLA	
mismatch	level,	recipient	primary	renal	disease,	and	donor	comorbid	
diseases.
The results for the multivariable analyses (both unadjusted 
and	adjusted)	are	shown	in	Table	5.	Numerically,	1‐year	and	5‐year	
patient	 and	graft	 survival	were	 superior	when	 the	donor’s	 cause	
of	death	was	by	 ligature	asphyxiation	than	by	other	causes,	both	
before	and	after	 confounder	adjustment	 (Table	5).	Delayed	graft	
function	 (DGF)	 and	 primary	 nonfunction	 (PNF)	 rates	were	 com‐
parable	 between	 recipients	 of	 kidneys	 from	donors	who	 died	 of	
ligature	 asphyxiation	 and	 those	 who	 received	 kidneys	 from	 all	
other deceased donors after adjustment for donor and recipient 
characteristics.
Of	the	21	682	deceased	donor	kidney	transplants	performed,	
18	059	 (83.4%)	were	 first‐time	 kidney	 transplant	 recipients.	 In	 a	
sensitivity	 analysis	 of	 first	 kidney–only	 transplants,	 patient	 and	
graft	survival	were	similar	 for	 those	who	received	their	 first	kid‐
ney	transplant	from	donors	who	died	following	ligature	asphyxia‐
tion	and	for	those	who	received	kidneys	from	all	other	deceased	
donors.
F I G U R E  3  Kaplan‐Meier	estimates	of	(A)	patient	survival	from	renal	transplantation	from	DCD	donors	who	died	following	ligature	
asphyxiation	and	all	other	DCD	donors,	and	(B)	death	censored	graft	survival	from	renal	transplantation	from	DCD	donors	who	died	
following	ligature	asphyxiation	and	all	other	DCD	donors.	DBD,	donation	after	brain	death;	DCD,	donation	after	circulatory	death
A B
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F I G U R E  4  Kaplan‐Meier	estimates	of	(A)	patient	survival	from	renal	transplantation	from	DCD	and	DBD	donors	who	died	following	
ligature	asphyxiation,	and	(B)	death	censored	graft	survival	from	renal	transplantation	from	DCD	and	DBD	donors	who	died	following	
ligature	asphyxiation.	DBD,	donation	after	brain	death;	DCD,	donation	after	circulatory	death
A B
F I G U R E  5  Kaplan‐Meier	estimates	of	(A)	patient	survival	from	renal	transplantation	from	donors	who	died	following	ligature	
asphyxiation	(both	DBD	and	DCD)	and	all	other	deceased	donors,	and	(B)	death	censored	graft	survival	from	renal	transplantation	from	
donors	who	died	following	ligature	asphyxiation	(both	DBD	and	DCD)	and	all	other	deceased	donors.	DBD,	donation	after	brain	death;	DCD,	
donation after circulatory death
A B
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TA B L E  5  Comparison	of	kidney	transplant	outcomes	by	donor	type	(DBD	and	DCD)	and	donor	death	secondary	to	ligature	asphyxiation
DBD donors following 
ligature asphyxiation 
(n = 294)
All other DBD donors 
(n = 14 382)
DCD donors following 
ligature asphyxiation 
(n = 356)
All other DCD donors 
(n = 6661)
Unadjusted ratio (95% CI) 
ligature asphyxiation vs. 
nonligature asphyxiation
Adjusted ratio (95% CI) 
ligature asphyxiation vs. 
nonligature asphyxiation
Adjusted 
P value
Primary‐non‐
function
1/262	(0.4%) 275	/12741	(2.2%) 8/320	(2.5%) 157/5899	(2.7%) OR	0.694	(0.357‐1.351) OR	0.989	(0.704‐1.388) .948
Delayed	graft	
function
40/262	(15.2%) 2778/12741	(21.8%) 116/320	(36.3%) 2377/5899	(40.3%) OR	0.946	(0.783‐1.142) OR	1.050	(0.952‐1.160) .325
1‐y	death	
censored	graft	
survival
96.8% 94.3% 95.6% 93.6% HR	0.638	(0.426‐0.955) HR	0.851	(0.565‐1.283) .442
5‐y	death	
censored	graft	
survival
92.8% 86.8% 92.2% 86.8% HR	0.557	(0.403‐0.771) HR	0.775	(0.564‐1.06) .115
1‐y	patient	
survival from 
transplanta‐
tion
97.5% 96.5% 97.9% 95.8% HR	0.613	(0.361‐1.041) HR	0.984	(0.585‐1.655) .951
5‐y	patient	
survival from 
transplanta‐
tion
91.9% 89.3% 92.4% 86.6% HR	0.667	(0.478‐0.932) HR	1.05	(0.757‐1.456) .772
1‐y	first	kidney	
death 
censored	graft	
survival 
(n	=	18	059)
97.8% 96.5% 98.0% 95.7% HR	0.619	(0.388‐0.987) HR	0.814	(0.506	1.307) .269
5‐y	first	kidney	
death 
censored	graft	
survival 
(n	=	18	059)
95.2% 88.4% 93.5% 87.3% HR	0.506	(0.343‐0.745) HR	0.705	(0483‐1.03) .07
12‐mo	eGFR	
(n	=	17	846)
61.4	(46.7‐	76.6)	
(n	=	238)	
50.4	(38.3‐	64.8)	
(n	=	11953)
57.9	(46.2‐	68.7)	
(n	=	299)
46.6	(34.9‐59.6)	
(n	=	5350)
PE	9.525	(7.482‐11.567) PE	0.686	(−1.103‐	2.476) .452
CI,	confidence	interval;	DBD,	donation	after	brain	death;	DCD,	donation	after	circulatory	death;	HR,	hazard	ratio;	OR,	odds	ratio;	PE,	parameter	estimate.
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Of	 the	 21	682	 deceased	 donor	 kidney‐only	 transplant	 recipi‐
ents,	18	258	(82.3%)	had	12‐month	posttransplant	serum	creatinine	
recorded	 and,	 of	 these,	 data	were	 available	 to	 calculate	 eGFR	 for	
18	216.	Twelve‐month	eGFR	were	significantly	higher	for	those	who	
received	kidneys	from	donors	who	died	from	ligature	asphyxiation	
(both	DCD	and	DBD)	(Figure	6).
To	examine	the	impact	that	donor	death	by	ligature	asphyxiation	
had	on	12‐month	posttransplant	eGFR,	a	multivariable	linear	regres‐
sion	model	was	fitted.	Following	adjustment	for	donor	and	recipient	
factors,	death	by	ligature	asphyxiation	was	not	an	independent	pre‐
dictor	of	12‐month	eGFR	(P	=	.452).
To	assess	whether	the	additional	warm	ischemic	insult	from	liga‐
ture	asphyxiation	in	DCD	donors	impacted	on	transplant	outcomes,	
a	separate	multivariable	analysis	of	such	donors	was	performed.	This	
revealed	that	even	after	adjusting	for	warm	 ischemic	time	 in	DCD	
donors	 there	was	no	difference	between	 transplant	outcomes	 for	
recipients	of	kidneys	from	DCD	donors	who	died	following	ligature	
asphyxiation	and	all	other	DCD	donors	(Table	S1).
To	 reduce	 the	 impact	 of	 potential	 bias	 from	 confounding	 vari‐
ables,	 a	 case‐control	 propensity	 score	 matched	 analysis	 was	 also	
performed.	Recipients	of	kidneys	 from	donors	who	died	 following	
ligature	asphyxiation	 (n	=	622)	were	matched	to	controls	based	on	
propensity	scores	generated	using	selected	donor	and	recipient	vari‐
ables	 (see	Methods).	This	analysis	 showed	all	 transplant	outcomes	
of	 recipients	 of	 kidneys	 from	 donors	 who	 died	 following	 ligature	
asphyxiation	 were	 similar	 to	 those	 in	 the	 matched	 control	 group	
(Table	 6).	 An	 additional	 case–control	 propensity	 score	 matched	
analysis	was	 performed	 comparing	 outcomes	 in	 recipients	 of	 kid‐
neys	from	DCD	donors	who	died	following	ligature	asphyxiation	and	
controls	who	received	DCD	donor	kidneys.	This	also	confirmed	that	
kidneys	 from	donors	who	died	 following	 ligature	asphyxiation	had	
similar	outcomes	to	matched	controls	(data	not	shown).
4  | DISCUSSION
Organ	donors	who	die	 following	 ligature	 asphyxiation	 represent	 a	
relatively small but important proportion of the overall deceased 
donor	population	(~3%	in	the	present	study).	Most	of	these	deaths	
result	 from	 attempted	 suicide	 by	 hanging	 and	 tragically	 the	 inci‐
dence	of	this	continues	to	increase,	predominantly	among	younger	
males	where	suicide	is	the	second	most	common	cause	of	death.1,15 
The	mode	of	death	following	ligature	asphyxiation	results	in	global	
tissue	hypoxia	 and	 the	effect	 that	 this	 has	on	end	organ	 function	
following	kidney	transplantation	has	never	been	fully	assessed.	The	
results of the present national cohort analysis clearly demonstrate 
that	the	outcomes	for	recipients	of	kidneys	from	both	DBD	and	DCD	
donors	who	have	died	following	ligature	asphyxiation	are	compara‐
ble	 to	 those	 for	 recipients	of	 kidneys	 from	donors	who	have	died	
from all other causes.
In	 the	 present	 analysis,	 approximately	 half	 of	 the	 donors	who	
died	 following	 ligature	 asphyxiation	were	DBD	donors.	Recipients	
of	kidneys	from	such	donors	had	similar	patient	survival	and	signifi‐
cantly	 better	 graft	 survival	 to	 those	of	 recipients	 of	 kidneys	 from	
all	other	DBD	donors	up	to	5	years.	Moreover,	DGF	and	12‐month	
eGFR	were	 significantly	 better	 in	 recipients	 of	 kidneys	 from	DBD	
donors	who	died	following	ligature	asphyxiation.	The	superior	out‐
comes	seen	in	recipients	of	kidneys	from	DBD	donors	who	died	fol‐
lowing	ligature	asphyxiation	is	likely	attributable	to	the	fact	that	such	
donors	were	younger	and	had	less	comorbid	disease	than	all	other	
DBD	donors.	 Indeed,	 after	 case	mix	 adjustment	 in	 a	multivariable	
analysis,	12‐month	eGFR	outcomes	were	 similar.	The	case‐control	
propensity score matched analysis also confirmed that transplant 
outcomes	 were	 comparable	 in	 recipients	 of	 kidneys	 from	 donors	
dying	from	ligature	asphyxiation	and	their	matched	controls.
It	 is	now	widely	accepted	that	while	recipients	of	kidneys	from	
DCD	donors	have	 increased	 rates	of	PNF	and	DGF,	 the	 long‐term	
clinical outcomes are comparable to those observed in recipients 
of	 kidneys	 from	DBD	 donors.11,16	 As	 observed	 with	 DBD	 donors	
who	died	following	ligature	asphyxiation,	recipients	of	kidneys	from	
DCD	donors	who	died	following	ligature	asphyxiation	had	superior	
transplant	 outcomes	 compared	 to	 those	 seen	 in	 recipients	 of	 kid‐
neys	from	all	other	DCD	donors.	The	additional	warm	ischemic	in‐
sult	from	ligature	asphyxiation	was	not	associated	with	an	increase	
in	either	PNF	or	DGF.	The	additional	analyses	of	DCD	donors	who	
died	 following	 ligature	 asphyxiation	 demonstrated	 that	 even	 after	
adjustment	for	warm	ischemic	time,	kidneys	from	such	donors	were	
not	associated	with	poorer	transplant	outcomes	than	recipients	of	
kidneys	from	all	other	DCD	donors.	This	conclusion	was	confirmed	
by a case–control propensity score matched analysis of recipients of 
kidneys	from	DCD	donors	who	died	following	ligature	asphyxiation	
and their matched controls.
There	 is	 little	 information	 in	 the	 literature	concerning	 the	out‐
come	 following	 transplantation	 with	 kidneys	 from	 either	 DBD	 or	
DCD	 donors	 who	 died	 following	 ligature	 asphyxiation.	 A	 major	
strength	of	the	present	registry	analysis	is	that	it	provides	the	first	
comprehensive analysis of transplant outcome in recipients of 
F I G U R E  6  Twelve‐month	eGFR	by	donor	type	and	whether	
the	donor	died	secondary	to	ligature	asphyxiation.	DBD,	donation	
after	brain	death;	DCD,	donation	after	circulatory	death;	eGFR,	
estimated	glomerular	filtration	rate
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kidneys	from	donors	who	died	following	ligature	asphyxiation.	The	
analysis	included	a	relatively	large	national	cohort	of	kidney	donors	
who	died	following	ligature	asphyxiation	with	a	large	proportion	of	
DCD donors.
As	for	all	retrospective	transplant	registry	analyses,	some	degree	
of	 caution	 is	 required	 in	 the	 interpretation	of	 the	 results	 because	
residual	confounding	factors	not	included	in	the	analysis	may	have	
influenced	 the	 findings,	 such	 as	 significant	 recipient	 comorbidity.	
In	 the	 present	 analysis,	 some	 degree	 of	 selection	 bias	 is	 likely	 to	
have	occurred.	For	example,	only	kidneys	from	younger	previously	
healthy	donors	who	died	following	 ligature	asphyxiation	may	have	
been	 preferentially	 selected	 for	 procurement	 and	 transplantation,	
thereby	limiting	the	general	applicability	of	the	present	findings.	If	
the	selection	criteria	for	use	of	kidneys	from	potential	donors	follow‐
ing	 ligature	asphyxiation	were	to	be	made	 less	stringent,	 it	cannot	
be	assumed	that	the	clinical	outcomes	would	be	equally	favorable.	
Interestingly,	the	present	analysis	showed	that	potential	organ	do‐
nors	who	died	 following	 ligature	 asphyxiation	were	more	 likely	 to	
donate	one	or	more	kidneys	for	transplantation	than	all	other	poten‐
tial	deceased	donors,	even	after	adjustment	for	key	favorable	donor	
factors	 including	donor	 age.	For	 those	donors	who	died	 following	
ligature	 asphyxiation,	 who	 had	 a	 cardiac	 arrest	 and	 an	 estimated	
“downtime”	before	restoration	of	circulation,	the	data	available	sug‐
gested	that	this	did	not	influence	whether	or	not	a	potential	donor	
proceeded	to	kidney	donation.	Donors	who	died	following	ligature	
asphyxiation	were	more	likely	to	proceed	to	kidney	donation	if	they	
had	a	history	of	 imprisonment	 (7.4%	of	 such	donors	had	a	history	
of	 imprisonment).	This	may	be	because	donors	who	died	by	hang‐
ing	while	incarcerated	had	a	shorter	time	to	resuscitation	but	this	is	
speculation.
Another	potential	weakness	of	the	study	is	that	donor	cause	
of	death	from	ligature	asphyxiation	was	not	one	of	the	65	report‐
able	 causes	 of	 death	 recorded	 in	 the	 transplant	 registry	 and	 so	
identification	of	such	donors	relied	on	manual	review	of	the	free	
text	 entries	 for	 all	 deceased	organ	donors	using	 specific	 search	
term	variables.	 It	 is	unlikely	 that	a	significant	number	of	donors	
who	died	following	ligature	asphyxiation	were	not	identified,	but	
it is possible that the numbers presented represent an underes‐
timate	of	potential	donors	who	died	following	ligature	asphyxia‐
tion.	The	dataset	used	in	the	present	study	had	very	little	missing	
data	for	most	of	the	key	variables.	However,	a	further	limitation	
of	 the	 analysis	 is	 that	 for	 some	 variables	missing	 data	may	 im‐
pact	on	the	results	and	their	interpretation.	There	were	very	few	
missing	data	on	graft	and	patient	survival	(<0.5%	overall	and	0%	
for	recipients	of	kidneys	from	donors	who	died	from	ligature	as‐
phyxiation).	In	the	case	of	12‐month	eGFR,	data	were	missing	in	
17.8%	of	the	entire	study	cohort,	but	this	was	distributed	equally	
between	recipients	who	received	kidneys	from	donors	who	died	
following	 ligature	 asphyxiation	 and	 those	 who	 did	 not,	 making	
bias	less	likely.
In	conclusion,	the	findings	from	the	present	analysis	show	that	
use	of	kidneys	from	both	DBD	and	DCD	donors	who	died	following	
TA B L E  6  Transplant	outcomes	in	a	1‐1	case‐control	propensity	score	matched	analysis	of	recipients	of	kidneys	from	donors	who	died	
following	ligature	asphyxiation	and	their	matched	controls.	Propensity	scores	were	estimated	using	the	following	donor	and	recipient	
variables:	donor	age,	recipient	age,	donor	past	medical	history	of	hypertension,	primary	renal	disease,	HLA	mismatch	grade,	cold	ischaemic	
time,	donor	weight,	donor	type	(DBD	and	DCD),	and	transplant	year
Recipients of kidneys from donors 
dying after ligature asphyxiation 
(n = 622) median propensity score, 
0.059 (0.031‐0.108)
Matched control recipients 
(n = 622) median propensity 
score, 0.060 (0.030‐ 0.105) 
Propensity score matched 
ligature asphyxiation vs. 
nonligature asphyxiation P value
Primary‐nonfunction 9/570	(1.6%) 11	/580	(1.9%) OR	1.083	(0.456‐2.569) .897
Delayed	graft	function 152/570	(26.7%) 132/580	(22.8%) OR	0.810	(0.619‐1.060) .687
1‐y	death	censored	graft	
survival
96.1% 96.3% HR	1.051	(0.593‐1.862) .865
5‐y	death	censored	graft	
survival
91.3% 89.2% HR	0.805	(0.537‐1.208) .295
1‐y	patient	survival	from	
transplantation
97.5% 97.8% HR	0.664	(0.347‐1.273) .218
5‐y	patient	survival	from	
transplantation
90.7% 92.5% HR	0.985	(0.640‐1.515) .945
1‐y	first	kidney,	death	
censored	graft	survival	
(n	=	1077)
96.6% 96.8% HR	1.06	(0.544‐2.046) .875
5‐y	first	kidney,	death	
censored	graft	survival	
(n	=	1077)
92.9% 90.9% HR	0.800	(0.499‐1.282) .353
12‐mo	eGFR	(n	=	1104) 61	(47‐74)	(n	=	535) 59	(47‐74)	(n	=	557) PE	1.575	(−3.392‐2.788) .848
HR,	hazard	ratio;	OR,	odds	ratio;	PE,	parameter	estimate.
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ligature	 asphyxiation	 result	 in	 excellent	 transplant	 outcomes.	 In	
view	of	this,	increasing	consideration	should	be	given	to	the	use	of	
kidneys	from	potential	donors	who	die	following	ligature	asphyx‐
iation	and	whose	kidneys	are	currently	declined	 for	 transplanta‐
tion.	To	inform	the	increased	use	of	such	kidneys,	the	concept	of	
total	global	tissue	hypoxia	from	initiation	of	ligature	asphyxiation	
to	cold	perfusion	of	the	kidney	with	preservation	solution	may	be	
helpful.	Global	hypoxia	begins	shortly	after	hanging	is	initiated	and	
extends	until	discovery	and	initiation	of	resuscitation:	its	duration	
is	highly	variable	and	in	many	cases	unknown.	In	most	patients	in	
the	present	cohort,	 this	was	followed	by	a	period	of	“downtime”	
extending	from	discovery	of	a	patient	with	no	cardiac	output	until	
cardiac output is successfully reestablished and the patient is 
transferred	to	a	critical	care	unit.	Currently,	a	minority	of	patients	
has	recorded	“downtimes”	and	there	is	a	need	for	improved	docu‐
mentation.	These	two	periods	of	global	tissue	hypoxia	are,	in	the	
case	of	DCD	donors,	followed	by	a	third	period	of	tissue	hypoxia	
from	the	time	of	withdrawal	of	 life	supporting	treatment	to	cold	
perfusion	of	the	kidneys,	the	duration	of	which	is	usually	well	doc‐
umented.	Although	making	an	assessment	of	the	total	duration	of	
global	tissue	hypoxia	is	often	problematic,	incorporating	this	con‐
cept	into	decision‐making	on	the	use	of	kidneys	from	donors	who	
die	following	ligature	asphyxiation	may	provide	a	basis	for	the	safe	
utilization	of	kidney	from	selected	donors	currently	being	declined	
for transplantation.
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